82
|
221
|
3e3gA |
H. influenzae beta-carbonic anhydrase, variant g41a |
68
|
182
|
3e1vA |
H. influenzae beta-carbonic anhydrase, variant d44n |
76
|
220
|
3e3iA |
H. influenzae beta-carbonic anhydrase, variant g41a with 100 mm bicarbonate |
72
|
186
|
3e24A |
H. influenzae beta-carbonic anhydrase, variant w39f |
77
|
258
|
3dvcA |
X-ray crystal structure of mutant n62t of human carbonic anhydrase ii |
75
|
258
|
3dv7A |
Role of hydrophilic residues in proton transfer during catalysis by human carbonic anhydrase ii (n62a) |
64
|
182
|
3e2xA |
H. influenzae beta-carbonic anhydrase, variant v47a |
73
|
258
|
3dvbA |
X-ray crystal structure of mutant n62v human carbonic anhydrase ii |
64
|
182
|
3e3fA |
H. influenzae beta-carbonic anhydrase, variant v47a with 100 mm bicarbonate |
78
|
221
|
3e28A |
H. influenzae beta-carbonic anhydrase, variant y181f |
76
|
258
|
3dvdA |
X-ray crystal structure of mutant n62d of human carbonic anhydrase ii |
68
|
183
|
3e31A |
H. influenzae beta-carbonic anhydrase, variant v47a |
77
|
257
|
3dc9A |
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties |
77
|
257
|
3dccA |
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties |
77
|
256
|
3dd8A |
Carbonic anhydrase inhibitors. interaction of the antitumor sulfamate emd-486019 with twelve mammalian isoforms: kinetic and x-ray crystallographic studies |
76
|
257
|
3dcsA |
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties |
75
|
258
|
3dd0A |
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties |
75
|
257
|
3d8wA |
Use of a carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties |
76
|
257
|
3d9zA |
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties |
74
|
257
|
3dazA |
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties |
76
|
257
|
3d93A |
Apo human carbonic anhydrase ii bound with substrate carbon dioxide |
76
|
258
|
3czvA |
Crystal structure of the human carbonic anhydrase xiii in complex with acetazolamide |
76
|
257
|
3dc3A |
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties |
71
|
257
|
3cyuA |
Human carbonic anhydrase ii complexed with cryptophane biosensor and xenon |
74
|
257
|
3d92A |
Human carbonic anhydrase ii bound with substrate carbon dioxide |
75
|
262
|
3da2A |
X-ray structure of human carbonic anhydrase 13 in complex with inhibitor |
81
|
263
|
3d0nA |
Crystal structure of human carbonic anhydrase xiii |
76
|
258
|
3cajA |
Crystal structure of the human carbonic anhydrase ii in complex with ethoxzolamide |
78
|
258
|
3c7pA |
Crystal structure of human carbonic anhydrase ii in complex with stx237 |
78
|
256
|
3ca2A |
Crystallographic studies of inhibitor binding sites in human carbonic anhydrase ii. a pentacoordinated binding of the scn-ion to the zinc at high p*h |
76
|
209
|
3bojA |
Carbonic anhydrase from marine diatom thalassiosira weissflogii- cadmium bound domain 1 without bound metal (cdca1-r1) |
75
|
209
|
3bobA |
Carbonic anhydrase from marine diatom thalassiosira weissflogii- cadmium bound domain 2 |
78
|
213
|
3bohA |
Carbonic anhydrase from marine diatom thalassiosira weissflogii- cadmium bound domain 1 with acetate (cdca1-r1) |
71
|
256
|
3bl1A |
Carbonic anhydrase inhibitors. sulfonamide diuretics revisited old leads for new applications |
77
|
209
|
3bocA |
Carbonic anhydrase from marine diatom thalassiosira weissflogii- zinc bound domain 2 (cdca1-r2) |
75
|
209
|
3boeA |
Carbonic anhydrase from marine diatom thalassiosira weissflogii- cadmium bound domain 2 with acetate (cdca1-r2) |
76
|
257
|
3bl0A |
Carbonic anhydrase inhibitors. interaction of 2-n,n-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with twelve mammalian isoforms: kinetic and x-ray crystallographic studies |
74
|
258
|
3betA |
Crystal structure of the human carbonic anhydrase ii in complex with stx 641 at 1.85 angstroms resolution |
91
|
357
|
3b1bA |
The unique structure of wild type carbonic anhydrase alpha-ca1 from chlamydomonas reinhardtii |
80
|
256
|
3b4fA |
Carbonic anhydrase inhibitors. interaction of 2-(hydrazinocarbonyl)-3-phenyl-1h-indole-5-sulfonamide with twelve mammalian isoforms: kinetic and x-ray crystallographic studies |
62
|
258
|
2zncA |
Murine carbonic anhydrase iv |
73
|
257
|
2x7uA |
Structures of human carbonic anhydrase ii inhibitor complexes reveal a second binding site for steroidal and non-steroidal inhibitors. |
75
|
257
|
2x7sA |
Structures of human carbonic anhydrase ii inhibitor complexes reveal a second binding site for steroidal and non-steroidal inhibitors. |
75
|
257
|
2x7tA |
Structures of human carbonic anhydrase ii inhibitor complexes reveal a second binding site for steroidal and non-steroidal inhibitors. |
77
|
258
|
2wehA |
Thermodynamic optimisation of carbonic anhydrase fragment inhibitors |
74
|
257
|
2wd3A |
Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template |
73
|
258
|
2wd2A |
A chimeric microtubule disruptor with efficacy on a taxane resistant cell line |
75
|
258
|
2wejA |
Thermodynamic optimisation of carbonic anhydrase fragment inhibitors |
76
|
257
|
2weoA |
Thermodynamic optimisation of carbonic anhydrase fragment inhibitors |
70
|
230
|
2w3nA |
Structure and inhibition of the co2-sensing carbonic anhydrase can2 from the pathogenic fungus cryptococcus neoformans |